Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 56 of 56 entries
View as:

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT06821061 Org: User:
Start: 02/10/25 End: 12/22/25 Due: 12/22/26

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04713553 Org: User:
Start: 02/15/21 End: 07/22/21 Due: 07/22/22

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06340568 Org: User:
Start: 06/30/25 End: 01/31/30 Due: 01/31/31

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT06683352 Org: User:
Start: 11/11/24 End: 06/22/25 Due: 06/22/26

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04683939 Org: User:
Start: 01/18/22 End: 07/24/23 Due: 07/24/24

A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04526899 Org: User:
Start: 05/19/21 End: 12/31/25 Due: 12/31/26